Clinical trial for Hearing Loss, Sensorineural
Official title Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
ClinicalTrials.gov ID: NCT05215197
What this study is testing
What is intracochlear platelet rich fibrin administration?
an investigational intra‑operative injection being studied as a potential treatment for sensorineural hearing loss in people receiving cochlear implants is designed to deliver autologous platelet‑rich fibrin to the round window to provide anti‑inflammatory factors that may reduce post‑surgical fibrosis
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to find out whether using a patient's own platelet‑rich fibrin during cochlear implantation can lower inflammation and scar formation.
- Who it's for
- Adults with sensorineural hearing loss who are scheduled for a cochlear implant.
- What's involved
- Participants will receive the fibrin gel inside the cochlea during surgery and will have standard follow‑up visits and hearing checks.
- Time commitment
- The study follows participants for several months after surgery with routine clinic visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with sensorineural hearing loss
- Patients who will have cochlear implant surgery with CI422 electrode
You likely can't join if
- Patients with cochlear abnormality
- Patients with auditory neuropathy
The study team makes the final eligibility decision.
Where it is enrolling
- Denizli, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Denizli, Turkey (Türkiye). Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.